Company / EPS (Basic)
IQVIA EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$7.39
FY2025
5-year range
$0.98 / $7.39
FY2021-FY2025
Trend
+27.0%
vs FY2024
Sector context
#23 of 160
Health Care
What the data says
IQVIA's eps (basic) of $7.39 is higher than 86% of companies in the Health Care sector (FY2025). EPS (Basic) has increased for 4 consecutive years, from $0.98 in FY2021 to $7.39 in FY2025.
Based on SEC 10-K filings.
7.39 in FY2025 with a 5-year CAGR of +42.2%. Top quartile in the Health Care sector.
Improved from $5.05 to $7.39 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +71.7%
- 5-Year CAGR
- +42.2%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 160This company $7.39 Sector average $1.57
▼
+369.4% above sector average
Key checks
Key Insights
- IQVIA's eps (basic) has grown for 4 consecutive years.
- In FY2025, eps (basic) increased 27.0% year-over-year.
- Ranks #23 out of 160 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.39 | +27.0% |
| FY2024 | $5.82 | +15.2% |
| FY2023 | $5.05 | +245.9% |
| FY2022 | $1.46 | +49.0% |
| FY2021 | $0.98 | -22.8% |
| FY2020 | $1.27 | -78.3% |
| FY2019 | $5.86 | +1120.8% |
| FY2018 | $0.48 | -84.8% |
| FY2017 | $3.15 | +13.3% |
| FY2016 | $2.78 | +51.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026